Sfoglia per Autore
The New Pyrimido-indole Compound CD-160130 Preferentially Inhibits the KV11.1B Isoform and Produces Antileukemic Effects Without Cardio-toxicity
2015 L Gasparoli; M D'Amico; M Masselli; S Pillozzi; R Caves; R Khuwaileh; W Tiedke; K Mugridge; A Pratesi; J Mitcheson; G Basso; A Becchetti; A Arcangeli
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug
2015 Brunetti, Jlenia; Pillozzi, Serena; Falciani, Chiara; Scali, S; Lozzi, L; Pini, A; Arcangeli, A; Menichetti, S; Bracci, L; Depau, L; Tenori, E
cis-Pt I2(NH3)2: a reappraisal
2015 Marzo, Tiziano; Pillozzi, Serena; Hrabina, Ondrej; Kasparkova, Jana; Brabec, Viktor; Arcangeli, Annarosa; Bartoli, Gianluca; Severi, Mirko; Lunghi, Alessandro; Totti, Federico; Gabbiani, Chiara; Quiroga, Adóracion G; Messori, Luigi
New gold carbene complexes as candidate anticancer agents
2016 Pratesi, Alessandro; Cirri, Damiano; Đurović, Mirjana D; Pillozzi, Serena; Petroni, Giulia; Bugarčić, Živadin D; Messori, Luigi
LH/hCG-Receptor Expression May Have a Negative Prognostic Value in Low-Risk Endometrial Cancer
2016 Noci, Ivo; Sorbi, Flavia; Mannini, Luca; Projetto, Elisabetta; Pillozzi, Serena; Ghizzoni, Viola; Lottini, Tiziano; Moncini, Daniela; Baroni, Gianna; Mungai, Francesco; Arcangeli, Annarosa; Fambrini, Massimiliano
Antiproliferative properties and biomolecular interactions of three Pd(II) and Pt(II) complexes
2016 Massai, Lara; Pratesi, Alessandro; Bogojeski, Jovana; Banchini, Marco; Pillozzi, Serena; Messori, Luigi; Bugarčić, Živadin D
Potent in vitro antiproliferative properties for a triplatinum cluster toward triple negative breast cancer cells
2016 Gabbiani, Chiara; Pratesi, Alessandro; Marchetti, Lorella; Casini, Angela; Leoni, Piero; Pillozzi, Serena; Crociani, Olivia; Bartoli, Gianluca; Messori, Luigi
Macrolide antibiotics exert antileukemic effects by modulating the autophagic flux through inhibition of hERG1 potassium channels
2016 Pillozzi, S.; Masselli, M.; Gasparoli, L.; D'Amico, M.; Polletta, L.; Veltroni, M.; Favre, C.; Basso, G.; Becchetti, A.; Arcangeli, A.
Cisplatin and its dibromido analogue: a comparison of chemical and biological profiles
2016 Marzo, Tiziano; Bartoli, Gianluca; Gabbiani, Chiara; Pescitelli, Gennaro; Severi, Mirko; Pillozzi, Serena; Michelucci, Elena; Fiorini, Benedetta; Arcangeli, Annarosa; Quiroga, Adóracion G.; Messori, Luigi
Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA = 1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties
2016 Battistin, F.; Scaletti, F.; Balducci, G.; Pillozzi, S.; Arcangeli, A.; Messori, L; Alessio, E.
The conformational state of hERG1 channels determines integrin association, downstream signaling, and cancer progression
2017 Becchetti, Andrea; Crescioli, Silvia; Zanieri, Francesca; Petroni, Giulia; Mercatelli, Raffaella; Coppola, Stefano; Gasparoli, Luca; D'Amico, Massimo; Pillozzi, Serena; Crociani, Olivia; Stefanini, Matteo; Fiore, Antonella; Carraresi, Laura; Morello, Virginia; Manoli, Sagar; Brizzi, Maria Felice; Ricci, Davide; Rinaldi, Mauro; Masi, Alessio; Schmidt, Thomas; Quercioli, Franco; Defilippi, Paola; Arcangeli, Annarosa
PtI2(DACH), the iodido analogue of oxaliplatin as a candidate for colorectal cancer treatment: chemical and biological features
2017 Cirri, D.; Pillozzi, S.; Gabbiani, C.; Tricomi, J.; Bartoli, G.; Stefanini, M.; Michelucci, E.; Arcangeli, A.; Messori, L; Marzo, T.
Circulating Endothelial Progenitor Cells in Type 1 Diabetic Patients: Relation with Patients' Age and Disease Duration.
2017 Arcangeli A, Lastraioli E, Piccini B, D'Amico M, Lenzi L, Pillozzi S, Calabrese M, Toni S, Arcangeli A
Engineering l-asparaginase for spontaneous formation of calcium phosphate bioinspired microreactors.
2018 Louka A, Matlahov I , Giuntini S , Cerofolini L , Cavallo A , Pillozzi S , Ravera E , Fragai M , Arcangeli A , Ramamoorthy A , Goobes G , Luchinat C
Pilot investigation of the mutation profile of PIK3CA/PTEN genes (PI3K pathway) in grade 3 endometrial cancer
2018 Malentacchi F, Turrini I, Sorbi F, Projetto E, Castiglione F, Fambrini M, Petraglia F, Pillozzi S, Noci I
Severe hypoxia selects hematopoietic progenitors with stem cell potential from primary Myelodysplastic syndrome bone marrow cell cultures.
2018 Masala E, Valencia-Martinez A, Pillozzi S, Rondelli T, Brogi A, Sanna A, Gozzini A, Arcangeli A, Dello Sbarba P, Santini V
Luteinizing Hormone/Human Chorionic Gonadotropin Receptor Immunohistochemical Score Associated with Poor Prognosis in Endometrial Cancer Patients.
2018 Sorbi F, Projetto E, Turrini I, Baroni G, Pillozzi S, Ghizzoni V, Vergoni F, Castiglione F, Malentacchi F, Fambrini M, Noci I
Chlorido and bromido oxaliplatin analogues as potential agents for CRC treatment: Solution behavior, protein binding and cytotoxicity evaluation
2018 Marzo, Tiziano; Pratesi, Alessandro; Cirri, Damiano; Pillozzi, Serena; Petroni, Giulia; Guerri, Annalisa; Arcangeli, Annarosa; Messori, Luigi; Gabbiani, Chiara
The combined activation of K Ca 3.1 and inhibition of K v 11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells
2018 Pillozzi, Serena; D'Amico, Massimo; Bartoli, Gianluca; Gasparoli, Luca; Petroni, Giulia; Crociani, Olivia; Marzo, Tiziano; Guerriero, Angela; Messori, Luigi; Severi, Mirko; Udisti, Roberto; Wulff, Heike; Chandy, K George; Becchetti, Andrea; Arcangeli, Annarosa*
hERG1 potassium channel expression predicts survival in clear-cell renal cell carcinoma: A pilot study with a long-term follow up
2019 Lastraioli, E.; Tellini, R.; Mari, A.; Pillozzi, S.; Fiore, A.; Venturini, S.; Scelzi, S.; Lapini, A.; Minervini, A.; Carini, M.; Nesi, G.; Arcangeli, A.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
The New Pyrimido-indole Compound CD-160130 Preferentially Inhibits the KV11.1B Isoform and Produces Antileukemic Effects Without Cardio-toxicity | 2015 | L Gasparoli; M D'Amico; M Masselli; S Pillozzi; R Caves; R Khuwaileh; W Tiedke; K Mugridge; A Pratesi; J Mitcheson; G Basso; A Becchetti; A Arcangeli | |
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug | 2015 | Brunetti, Jlenia; Pillozzi, Serena; Falciani, Chiara; Scali, S; Lozzi, L; Pini, A; Arcangeli, A; Menichetti, S; Bracci, L; Depau, L; Tenori, E | |
cis-Pt I2(NH3)2: a reappraisal | 2015 | Marzo, Tiziano; Pillozzi, Serena; Hrabina, Ondrej; Kasparkova, Jana; Brabec, Viktor; Arcangeli, Annarosa; Bartoli, Gianluca; Severi, Mirko; Lunghi, Alessandro; Totti, Federico; Gabbiani, Chiara; Quiroga, Adóracion G; Messori, Luigi | |
New gold carbene complexes as candidate anticancer agents | 2016 | Pratesi, Alessandro; Cirri, Damiano; Đurović, Mirjana D; Pillozzi, Serena; Petroni, Giulia; Bugarčić, Živadin D; Messori, Luigi | |
LH/hCG-Receptor Expression May Have a Negative Prognostic Value in Low-Risk Endometrial Cancer | 2016 | Noci, Ivo; Sorbi, Flavia; Mannini, Luca; Projetto, Elisabetta; Pillozzi, Serena; Ghizzoni, Viola; Lottini, Tiziano; Moncini, Daniela; Baroni, Gianna; Mungai, Francesco; Arcangeli, Annarosa; Fambrini, Massimiliano | |
Antiproliferative properties and biomolecular interactions of three Pd(II) and Pt(II) complexes | 2016 | Massai, Lara; Pratesi, Alessandro; Bogojeski, Jovana; Banchini, Marco; Pillozzi, Serena; Messori, Luigi; Bugarčić, Živadin D | |
Potent in vitro antiproliferative properties for a triplatinum cluster toward triple negative breast cancer cells | 2016 | Gabbiani, Chiara; Pratesi, Alessandro; Marchetti, Lorella; Casini, Angela; Leoni, Piero; Pillozzi, Serena; Crociani, Olivia; Bartoli, Gianluca; Messori, Luigi | |
Macrolide antibiotics exert antileukemic effects by modulating the autophagic flux through inhibition of hERG1 potassium channels | 2016 | Pillozzi, S.; Masselli, M.; Gasparoli, L.; D'Amico, M.; Polletta, L.; Veltroni, M.; Favre, C.; Basso, G.; Becchetti, A.; Arcangeli, A. | |
Cisplatin and its dibromido analogue: a comparison of chemical and biological profiles | 2016 | Marzo, Tiziano; Bartoli, Gianluca; Gabbiani, Chiara; Pescitelli, Gennaro; Severi, Mirko; Pillozzi, Serena; Michelucci, Elena; Fiorini, Benedetta; Arcangeli, Annarosa; Quiroga, Adóracion G.; Messori, Luigi | |
Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA = 1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties | 2016 | Battistin, F.; Scaletti, F.; Balducci, G.; Pillozzi, S.; Arcangeli, A.; Messori, L; Alessio, E. | |
The conformational state of hERG1 channels determines integrin association, downstream signaling, and cancer progression | 2017 | Becchetti, Andrea; Crescioli, Silvia; Zanieri, Francesca; Petroni, Giulia; Mercatelli, Raffaella; Coppola, Stefano; Gasparoli, Luca; D'Amico, Massimo; Pillozzi, Serena; Crociani, Olivia; Stefanini, Matteo; Fiore, Antonella; Carraresi, Laura; Morello, Virginia; Manoli, Sagar; Brizzi, Maria Felice; Ricci, Davide; Rinaldi, Mauro; Masi, Alessio; Schmidt, Thomas; Quercioli, Franco; Defilippi, Paola; Arcangeli, Annarosa | |
PtI2(DACH), the iodido analogue of oxaliplatin as a candidate for colorectal cancer treatment: chemical and biological features | 2017 | Cirri, D.; Pillozzi, S.; Gabbiani, C.; Tricomi, J.; Bartoli, G.; Stefanini, M.; Michelucci, E.; Arcangeli, A.; Messori, L; Marzo, T. | |
Circulating Endothelial Progenitor Cells in Type 1 Diabetic Patients: Relation with Patients' Age and Disease Duration. | 2017 | Arcangeli A, Lastraioli E, Piccini B, D'Amico M, Lenzi L, Pillozzi S, Calabrese M, Toni S, Arcangeli A | |
Engineering l-asparaginase for spontaneous formation of calcium phosphate bioinspired microreactors. | 2018 | Louka A, Matlahov I , Giuntini S , Cerofolini L , Cavallo A , Pillozzi S , Ravera E , Fragai M , Arcangeli A , Ramamoorthy A , Goobes G , Luchinat C | |
Pilot investigation of the mutation profile of PIK3CA/PTEN genes (PI3K pathway) in grade 3 endometrial cancer | 2018 | Malentacchi F, Turrini I, Sorbi F, Projetto E, Castiglione F, Fambrini M, Petraglia F, Pillozzi S, Noci I | |
Severe hypoxia selects hematopoietic progenitors with stem cell potential from primary Myelodysplastic syndrome bone marrow cell cultures. | 2018 | Masala E, Valencia-Martinez A, Pillozzi S, Rondelli T, Brogi A, Sanna A, Gozzini A, Arcangeli A, Dello Sbarba P, Santini V | |
Luteinizing Hormone/Human Chorionic Gonadotropin Receptor Immunohistochemical Score Associated with Poor Prognosis in Endometrial Cancer Patients. | 2018 | Sorbi F, Projetto E, Turrini I, Baroni G, Pillozzi S, Ghizzoni V, Vergoni F, Castiglione F, Malentacchi F, Fambrini M, Noci I | |
Chlorido and bromido oxaliplatin analogues as potential agents for CRC treatment: Solution behavior, protein binding and cytotoxicity evaluation | 2018 | Marzo, Tiziano; Pratesi, Alessandro; Cirri, Damiano; Pillozzi, Serena; Petroni, Giulia; Guerri, Annalisa; Arcangeli, Annarosa; Messori, Luigi; Gabbiani, Chiara | |
The combined activation of K Ca 3.1 and inhibition of K v 11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells | 2018 | Pillozzi, Serena; D'Amico, Massimo; Bartoli, Gianluca; Gasparoli, Luca; Petroni, Giulia; Crociani, Olivia; Marzo, Tiziano; Guerriero, Angela; Messori, Luigi; Severi, Mirko; Udisti, Roberto; Wulff, Heike; Chandy, K George; Becchetti, Andrea; Arcangeli, Annarosa* | |
hERG1 potassium channel expression predicts survival in clear-cell renal cell carcinoma: A pilot study with a long-term follow up | 2019 | Lastraioli, E.; Tellini, R.; Mari, A.; Pillozzi, S.; Fiore, A.; Venturini, S.; Scelzi, S.; Lapini, A.; Minervini, A.; Carini, M.; Nesi, G.; Arcangeli, A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile